Localized innovative oncology therapies (e.g., osimertinib)

About R-Pharm

R-Pharm is a major, fully-integrated Russian pharmaceutical player with a strategic focus on localizing advanced drug production and developing innovative therapies. The company leverages extensive partnerships with global biopharma leaders to in-license and co-develop products for the Russian and CIS markets, while also advancing its own R&D pipeline. Its significant manufacturing capabilities and government contracts position it as a key domestic supplier, particularly in oncology and critical care. The company's strategy is heavily aligned with Russia's national pharmaceutical import substitution policies.

Therapeutic Areas

Other Non-Small Cell Lung Cancer (NSCLC) Drugs